Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Cureus|June 3, 2026
A Diagnostic Challenge in the Emergency Department: Acute Intermittent Porphyria Unmasked After Cabergoline ExposureChristeen Mina, Hady Ghanem, Nancy MatarAmerican Journal of Hematology|November 11, 2011
Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogeneticsHady Ghanem, Niki Tank, Imad A TabbaraLeukemia & Lymphoma|September 11, 2012
The role of clofarabine in acute myeloid leukemiaHady Ghanem, Hagop Kantarjian, Maro Ohanian, et al.Autopsy & Case Reports|May 10, 2021
Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitorsRita Nader, Esther Tannoury, Tamina Rizk, et al.AACE Clinical Case Reports|November 27, 2020
DIABETIC KETOACIDOSIS ASSOCIATED WITH ALPELISIB TREATMENT OF METASTATIC BREAST CANCERStephanie J Farah, Nohad Masri, Hady Ghanem, et al.Expert Review of Anticancer Therapy|December 22, 2007
Targeted therapy in chronic myeloid leukemiaElias Jabbour, Jorge E Cortes, Hady Ghanem, et al.Expert Review of Hematology|November 19, 2010
Clofarabine in leukemiaHady Ghanem, Elias Jabbour, Stefan Faderl, et al.Clinical Hematology International|October 1, 2021
Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell LymphomaRita Assi, Nohad Masri, Iman Abou Dalle, et al.Frontiers in Oncology|March 13, 2026
Prognostic factors in young patients with oral cavity cancer: a systematic review and meta-analysis of 24 studiesRami Saade, Rita Khoury, Jana Hassan, et al.International Journal of Molecular Sciences|June 26, 2026
Resistance to EGFR Inhibitors in NSCLC: Mechanistic Insights and Emerging TherapiesRita Khoury, Chris Raffoul, Colette Hanna, et al.Pageof 3